BioSpace News Archive

Terrace Global Inc. (“Terrace Global” or the “Company”) (TSXV:TRCE) is pleased to announce it has filed its interim unaudited financial results for the quarter ended June 30, 2020.

Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces financial results for Q3 2020.

Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX) (“Entasis”), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced today it has entered into a definitive agreement to sell securities in a private placement with Innoviva, Inc

Ellipsis Health, pioneer of the first commercial-grade voice-based vital signs to quantify and manage depression and anxiety symptoms at scale, has announced the general availability of the Rising Higher mobile app.

Transcenta Holding Limited (“Transcenta”), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced today that the first subject has been dosed successfully on August 28th in China Phase I clinical trial of TST001, a humanized Claudin

Ernst & Young LLP (EY US) today announced that Maria Bennett, President, CEO and Founder of SPR Therapeutics, Inc. ® was named an Entrepreneur Of The Year ® 2020 East Central Award finalist. Now in its 34th year, the Entrepreneur Of The Year program honors entrepreneurial business leaders whose ambitions deliver innovation, growth and prosperity as they build and sustain successful businesses that transform our world. Bennett was selected as o

Following the devastating news of the death of the world’s beloved Black Panther, Chadwick Boseman, from colorectal cancer, many were left asking why – and how. What most don’t know is that Chadwick Boseman sat at the intersection of where colorectal cancer rates are among the highest and rising the fastest.

Origin Agritech Ltd. (NASDAQ: SEED) (the “Company” or “Origin”), an agriculture technology company, today announced that it will be presenting at the LD 500 investor conference on Friday, September 4th at 8 AM PST / 11 AM EST. Origin’s Chairman and Chief Executive Officer, Dr. Gengchen Han will be presenting to a live virtual audience

A grassroots medical society today urged the FDA to remove boxed warnings from ultrasound contrast agents (UCAs), citing compelling scientific data demonstrating their safety and life-saving potential.

Pharmascience Inc. is recalling one lot of prescription PMS-Ranitidine as a precaution after tests found NDMA, a nitrosamine impurity, at close to the accepted level.